November 29th and 30th, 2024
BASL Winter Meeting and Liver Course
Location
Van Diepenbeeckstraat 12, 2018 Antwerpen
Inrit parking
Lamorinièrestraat 53
2018 Antwerpen
Friday 29 November 2024
BASL Winter Meeting program: Alcohol related liver disease
8.30-9.00 Registration
09.00-10.15 Session 1: HEPATOLOGY UPDATE
Moderators: Thomas Vanwolleghem and Eric Trepo
- MASH CPG: update: Elisabetta Bugianesi (University of Torino, Italy)
- Benign Tumours: Jean Charles Nault (Paris Descartes Universite, France)
10.15-10.45 COFFEE BREAK
10.45-12.00 Session 2: NON-INTERACTIVE DISCUSSION OF CLINICAL CASES
Moderators: Filip Janssens and Marie de Vos
12.00-12.15 Presentations of BASL YOUNG INVESTIGATORS AWARDS LAUREATES 2024 and short presentation by 2023 Laureates
12.15-12.30 BASL awards for the best clinical and basic publications 2023
(Thomas Vanwolleghem)
12:30-12:40 BASL Extraordinary General Assembly
(Thomas Vanwolleghem)
12.40-13.30 LUNCH
13.30-15.00 Session 3: Alcohol-related liver disease (first part)
Moderators: Pierre Deltenre and Anja Geerts
- Epidemiology and Diagnosis – Peter Stärkel (UCLouvain, Belgium)
- Alcohol use disorder – Philippe de Timary (UCLouvain, Belgium)
- Indications for liver transplantation in alcoholic hepatitis and alcohol-related liver disease and impact of alcohol relapse after transplantation – Philippe Mathurin (University Hospital Lille, France)
15.00-15.15 COFFEE BREAK
15.15-16.45 Session 4: Alcohol-related liver disease (second part)
Moderators: Wim Laleman and Sergio Negrin Dastis
- MetALD: How to deal with it? – A Krag (Odense University Hospital, Denmark)
- Home monitoring for patients with decompensated cirrhosis – Raj Mookerjee (University College London, UK)
- Non-oncological palliative care in hepatology – Natalie Décosterd (University Hospital of the canton Vaud, Lausanne, Switzerland)
16.45-17.00 Conclusions and farewell
Saturday 30 November 2024
Liver Course program: Viral hepatitis
8.30-9.00 Registration
9.00-10.45 Session 1: Viral Hepatitis B/D: current and future treatment, special populations
Moderators: Marie Coessens and Pierre Deltenre
- Hepatitis B & D: clinical implications, current treatment
Thomas Vanwolleghem (University of Antwerp) - Hepatitis B: Immunology and future therapeutics
Patrick Kennedy (University of London) - Viral hepatitis in immunocompromised patients and pregnancy
Thomas Sersté (CHU Saint-Pierre/CUB, Brussels)
10.45-11.15 COFFEE BREAK
11.15-13.00 Session 1: Other viral hepatitis infections
Moderators: Sander Lefere and Wim Verlinden
- Hepatitis C
Sergio Negrin-Dastis (Grand Hopital de Charleroi/UCL Saint Luc, Brussels) - Hepatitis A en E: translational insights
Sven Pischke (University of Hamburg) - Clinical importance of non-A-to-E hepatitis (including adenovirus hepatitis in children)
Michael Peeters (Sciensano, Brussels)
13.00 Conclusion and farewell (Sander Lefere, BASL)